جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

42 مُخرَج نتائج البحث عن «Chitosan»

مقالوصول مغلق20264استشهاد· Semantic Scholar

Folate-functionalized chitosan nanoparticles: a versatile platform for targeted drug delivery and biomedical applications

International Journal of Polymeric Materials · مجلد 75 (8) · 835-858

Folate-conjugated chitosan nanoparticles represent a promising advancement in targeted drug delivery, offering enhanced specificity, biocompatibility, and controlled release profiles. Chitosan, a versatile biopolymer, provides a stable platform for nanoparticle synthesis, while folate conjugation enables selective targeting of folate receptors, which are overexpressed in various cancers and inflammatory diseases. This review explores the structural and functional properties of chitosan, mechanisms of folate receptor-mediated endocytosis, and innovative strategies for nanoparticle synthesis and functionalization. The review entails key formulation techniques, including nanopreci­pitation, ionic gelation, and spray drying, alongside characterization methods essential for optimizing therapeutic efficacy. The biomedical applications of Folate-conjugated chitosan nanoparticles are highlighted in cancer therapy, gene delivery, and anti-inflammatory treatments, with an emphasis on emerging trends such as CRISPR-based targeting and dual-ligand strategies. This review critically examines the existing challenges and explores future directions, highlighting the promising role of folate-conjugated chitosan nanoparticles in the evolution of precision medicine.

targeted drug deliveryfolate receptorreceptor-mediated endocytosisnanoprecipitation
مراجعةوصول مغلق202533استشهاد· Semantic Scholar

Exploring the Properties of Carboxymethyl Cellulose Blended With Other Polymeric Compounds for the Formulation of Biodegradable Packaging Films and Edible Coatings: A Review

Comprehensive Reviews in Food Science and Food Safety · مجلد 24 (4) · e70215-e70215

Carboxymethyl cellulose (CMC) is a leading hydrocolloid for biodegradable packaging films and edible coatings due to its film-forming ability, biodegradability, and nontoxicity. However, its application is limited by moisture sensitivity, poor mechanical strength, flammability, and inadequate gas barrier properties. This review explores the formulation, structural properties, and practical applications of CMC when blended with other polymeric compounds such as cellulose, starch, alginate, chitosan, and polylactic acid to overcome these limitations. Blending enhances tensile strength, water resistance, and antimicrobial functionality, extends food shelf life, and reduces reliance on synthetic plastics. Nanocomposite techniques and bioactive molecule incorporation further improve film performance. Innovative processing methods, including electrospinning and three-dimensional printing, offer new opportunities for structural enhancement. This literature review aims to assess key challenges, including material compatibility, processing efficiency, scalability, and environmental sustainability. CMC-based films, especially in composite formulations, show significant promise in advancing sustainable food packaging. However, for widespread industrial adoption, optimized formulations and ecoefficient production techniques are essential.

carboxymethyl cellulosebiodegradable packaging filmsedible coatingspolymer blends
مقالوصول مفتوح20253استشهاد· Semantic Scholar

Synergistic effects of berberine and curcumin-loaded chitosan nanoparticles in Nile tilapia: mitigating high-carbohydrate diet-induced metabolic dysfunction, hepatic injury, and immune-inflammatory responses

Italian Journal of Animal Science · مجلد 24 (1) · 1689-1707

This study is the first to explore the effects of dietary supplementation with chitosan nanoparticles (CHNPs) loaded with berberine (B) and curcumin (CR), either individually or in combination, within high-carbohydrate diets (HCD) on growth performance, health status, and immune-inflammatory gene expression in Nile tilapia. A total of 150 healthy Oreochromis niloticus fingerlings (8.21 ± 0.08 g) were randomly assigned to five groups: control (29% carbohydrate), HCD (42% carbohydrate), and three supplemented groups; B-CHNPs (100 mg berberine/kg HCD), CR-CHNPs (100 mg curcumin/kg HCD), and B-CR-CHNPs (100 mg berberine + curcumin (50:50)/kg HCD) for 100 days. The B-CR-CHNPs treatment significantly enhanced growth, feed utilisation, protein efficiency, digestive enzyme activities, blood protein levels, liver function, and lipid metabolism compared to the HCD group (p < 0.05). Dietary supplementation with Berberine and Curcumin effectively reversed the aberrant changes in liver tissues caused by HCD, restoring hepatic morphology to a state closely resembling normal conditions. Additionally, the dietary treatments significantly enhanced antioxidant status by reducing malonaldehyde levels and increasing total antioxidant capacity and superoxide dismutase activity. B-CR-CHNPs treatment effectively restored the suppressed expression of IgM and LZM genes in the liver of HCD-fed fish. In contrast, the elevated hepatic expression of pro-inflammatory genes TNF-α and IL-1β induced by the HCD was significantly reduced, with the greatest reduction observed in the B-CR-CHNPs group. Berberine and Curcumin showed strong binding to antioxidant, immune, and inflammatory targets. Supplementing Nile tilapia diets with 100 mg B-CR-CHNPs improved growth and mitigated HCD-induced liver damage by modulating metabolism, immunity, and redox balance.

berberinecurcuminchitosan nanoparticlesOreochromis niloticus
مقالوصول مفتوح20253استشهاد· Semantic Scholar

Impact of propolis and/ or chitosan nanoparticles on H1N1 influenza A virus: In vitro study

Journal of Radiation Research and Applied Sciences · مجلد 18 (2) · 101537-101537

Objective The H1N1 influenza A virus is the leading cause of seasonal flu outbreaks in humans. Even if there are vaccines for it, it still causes devastating outbreaks and a lot of money to lose. This study aimed to investigate the antiviral efficacy of chitosan nanoparticles and/or propolis against the H1N1 virus. Methods Nanoparticles were synthesized and characterized by transmission electron microscope (TEM). Cytotoxicity was assessed using the MTT assay on Vero cells, and antiviral efficacy was evaluated by calculating the median tissue culture infectious dose (TCID 50 ). Results Chitosan nanoparticles, with average diameters of 100–200 nm were successfully integrated with propolis extract forming rounded aggregates with average diameters ranging between 200 and 300 nm. Remarkably, cytotoxic concentrations against Vero cells for chitosan nanoparticles, propolis extract, and a combination of the two were 277.40 ± 14.94, 238.60 ± 12.25, and 440.10 ± 18.17 μg/mL, respectively. These concentrations indicate high cell viability (>90 %) at doses of 50, 50, and 100 μg/mL, respectively. To evaluate their antiviral effectiveness, the TCID 50 ratios of viral suspensions treated with propolis extract and/or chitosan nanoparticles were compared to those of untreated controls. The results showed that the antiviral activity against the H1N1 influenza A virus improved as the concentration of propolis alone or in the mixture increased, whereas chitosan nanoparticles alone did not exhibit antiviral properties. Conclusions The findings shed light on the possible uses of propolis and chitosan as antiviral drugs against the H1N1 influenza A virus, which are novel, safe, and effective.

H1N1 influenzapropolischitosan nanoparticlesantiviral activity
مقالوصول مفتوح20253استشهاد· Semantic Scholar

Chitosan-coated superparamagnetic iron oxide nanoparticles synthesized using Carica papaya bark extract: Evaluation of antioxidant, antibacterial, and anticancer activity of HeLa cervical cancer cells

Green Processing and Synthesis · مجلد 14 (1)

Abstract This study presents an eco-friendly approach for synthesizing chitosan-coated superparamagnetic iron oxide nanoparticles (Ch-SPIONs) using Carica papaya bark extract as a green reducing and stabilizing agent. The phytochemicals present in the bark extract facilitate the formation of SPIONs with well-defined magnetic characteristics. Comprehensive characterization through UV-visible spectroscopy, X-ray diffraction, scanning and transmission electron microscopy, energy-dispersive X-ray spectroscopy, and Fourier-transform infrared spectroscopy confirmed the successful synthesis of Ch-SPIONs. The nanoparticles exhibited an average size range of 50–80 nm with a rectangular morphology and a UV-vis absorption peak at 300 nm. The antioxidant potential of Ch-SPIONs was evaluated, revealing concentration-dependent scavenging activity that surpassed standard antioxidants at higher concentrations. Antibacterial assays demonstrated significant efficacy against Klebsiella pneumoniae (15 mm inhibition zone) and Staphylococcus aureus (20 mm inhibition zone). Furthermore, in vitro cytotoxicity studies on HeLa cervical cancer cells showed dose-dependent cell death, with an IC 50 value of 18 ± 0.4 μg·mL −1 , compared to 11 ± 0.5 μg·mL −1 for doxorubicin. Apoptotic induction and cell cycle disruption were further validated through fluorescence microscopy and flow cytometry. These findings underscore the potential of Carica papaya -mediated Ch-SPIONs as a sustainable, biocompatible nanomaterial for anticancer and antimicrobial applications, offering a promising alternative to conventional synthesis methods.

green synthesisantioxidant activityantibacterial activityKlebsiella pneumoniae
مقالوصول مفتوح20252استشهاد· Semantic Scholar

Anti-aflatoxigenic effect of Lactobacillus rhamnosus and its synbiotic combination of chitosan/ZnO in milk

AMB Express · مجلد 15 (1) · 165-165

Aflatoxin contamination of milk is a serious health concern. When animals ingested food contaminated with aflatoxin B1 (AFB1), it would be converted into aflatoxin M1 (AFM1) and secreted in the milk. This carcinogenic and hepatotoxic toxin could be overcome by biological methods. Therefore, this study aimed to assess the anti-aflatoxigenic effect of the probiotic Lactobacillus rhamnosus (L. rhamnosus) ATCC 7469, as well as its synbiotic combination with chitosan ZnO nanocomposite using ELISA. This is carried out by measuring AFM1 concentration in 90 milk samples, including 73 raw and 27 powdered milk samples. The average AFM1 concentration was 11.22 ± 11.31 and 10.62 ± 8.08 µg/kg, which exceeded the international regulatory limits for raw and powdered milk, respectively. All milk samples were treated with L. rhamnosus ATCC 7469 and a synbiotic combination of chitosan/ZnO nanocomposite and L. rhamnosus ATCC 7469. The results showed that the probiotic L. rhamnosus ATCC 7469, and the synbiotic combination significantly reduced the AFM1 concentration in milk (p value ≤ 0.05). The used probiotic bacteria showed binding to AFM1 from 10 to 83.8%, while the binding range increased to 34-92% after treating milk with the synbiotic combination. In conclusion, the biological treatment of milk using the probiotic, L. rhamnosus ATCC 7469, alone or in combination with chitosan/ZnO nanocomposite, is an efficient method for reducing the AFM1 concentration in milk. This study highlights the use of both metal nanoparticles (as a prebiotic) and probiotics, forming a synbiotic approach to control milk contamination with aflatoxins in the laboratory.

aflatoxin M1aflatoxin B1Lactobacillus rhamnosussynbiotics
مقالمفتوح (مستودع)20252استشهاد· Semantic Scholar

Impacts of Ficus Religiosa-loaded chitosan nanoparticles against indomethacin induced peptic ulcer in rats: promising therapy with enhanced bioavailability and gastro-protective activity

Toxicology Research · مجلد 14 (3) · tfaf034-tfaf034

Abstract Peptic ulcer is a chronic inflammatory disorder affecting large portion of population with difficulty in treatment. Treatment options include inhibition of gastric acid secretion, histamine inhibitors, eradication of Helicobacter pylori infection and tissue lining protection. These therapeutic options have several side effects, low bioavailability and bio-distribution. To further increase bioavailability, control release, stability, site specific delivery and minimize organoleptic side effects of phytochemical, nano-encapsulation is a suitable strategy. Chitosan is a suitable nano-carrier for drug delivery applications in treating peptic ulcer as it is biodegradable, biocompatible, safe and cost-effective. Therefore, Ficus religiosa (FR) leaf extract was loaded into chitosan NPs by ion gelation method for in vivo anti-ulcerative activity in indomethacin-induced peptic ulcer rats. Results showed that FR extract was successfully loaded into CNPs with 84% encapsulation efficiency while the size of empty CNPs was reported to be 620.3 nm as compared to FR-loaded CNPs 811.5 nm. FR-loaded CNPs showed homogeneous size distribution as well greater physical stability. Furthermore, in vivo studies revealed gastro-protective activity of FR-loaded CNPs in reducing the ulcer index (UI) to 0.51 (71.30% inhibition) while indomethacin only untreated rats showed UI 2.99 and insignificant ulcer inhibition 11.02%. Furthermore, FR-loaded CNPs restored gastric pH, healed rat stomach completely without ulcers or hemorrhagic spot and improved antioxidants and blood profiles compared to plant extract or CNPs. These findings confirmed the effective application of FR extract loaded CNPs as anti-ulcer agents and reinforces the importance of nano-encapsulation in improving drug efficacy.

Ficus religiosachitosan nanoparticlesnanoencapsulationionic gelation
مقالمفتوح (مستودع)20252استشهاد· Semantic Scholar

A Novel Facile and Efficient Prophylaxis Avenue of Chitosan Oligosaccharide/PLGA Based Polydatin Loaded Nanoparticles Against Bleomycin-Induced Lung Inflammation in Experimental Rat Model

AAPS PharmSciTech · مجلد 26 (1) · 35-35

Lung inflammation is a hallmark of several respiratory diseases. Despite the great effectiveness of the synthetic antiinflammatory agents, they cause potential side effects. Polydatin (PD), a natural phytomedicine, has antioxidant and antiinflammatory effects. Its clinical applications are hindered due to poor aqueous solubility, low bioavailability, and rapid metabolism by first-pass effect. Herein, we report the development of a novel chitosan oligosaccharide-coated PD-loaded Poly dl-lactide-co-glycolide nanoparticles (COS-coated PD/PLGA NPs) against a bleomycin-induced pulmonary inflammation in a rat model. The NPs exhibited a small particle size of 188.57 ± 5.68 nm and a high zeta potential of + 18.13 ± 2.75 mV with spherical architecture and sustained release pattern of PD. In vivo studies in bleomycin-induced lung inflammation in a rat model revealed the superior prophylactic activity of COS-coated PD/PLGA NPs over the free drug (PD) as demonstrated by histopathological and immunohistochemical analyses, alongside biochemical assays evaluating oxidative stress biomarkers and inflammatory cytokine levels. Overall, the optimized COS-coated PD/PLGA NPs formulation offers a promising prophylactic platform against many respiratory diseases.

polydatinPLGA nanoparticlesbleomycin-induced lung injurylung inflammation
مقالوصول مفتوح202411استشهاد

Preparation and Characterization of Novel Polyelectrolyte Liposomes Using Chitosan Succinate Layered over Chitosomes: A Potential Strategy for Colon Cancer Treatment

Biomedicines · مجلد 12 (1) · 126-126

Chitosan succinate is distinguished by its ability to shield the loaded drug from the acidic environment, localize and keep the drug at the colon site, and release the drug over an extended time at basic pH. The current study attempts to develop polyelectrolyte liposomes (PEL), using chitosan and chitosan succinate (CSSC), as a carrier for liposomal-assisted colon target delivery of 5 fluorouracil (5FU). The central composite design was used to obtain an optimized formulation of 5FU-chitosomes. The chitosan-coated liposomes (chitosomes) were prepared by thin lipid film hydration technique. After that, the optimized formulation was coated with CSSC, which has several carboxylic (COOH) groups that produce an anionic charge that interacts with the cation NH2 in chitosan. The prepared 5FU-chitosomes formulations were evaluated for entrapment efficiency % (EE%), particle size, and in vitro drug release. The optimized 5FU-chitosomes formulation was examined for particle size, zeta potential, in vitro release, and mucoadhesive properties in comparison with the equivalent 5FU-liposomes and 5FU-PEL. The prepared 5FU-chitosomes exhibited high EE%, small particle size, low polydispersity index, and prolonged drug release. PEL significantly limited the drug release at acidic pH due to the deprotonation of carboxylate ions in CSSC, which resulted in strong repulsive forces, significant swelling, and prolonged drug release. According to a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, PEL treatment significantly decreased the viability of HT-29 cells. When compared to 5FU-liposome and 5FU-chitosome, the in vivo pharmacokinetics characteristics of 5FU-PEL significantly (p < 0.05) improved. The findings show that PEL enhances 5FU permeability, which permits high drug concentrations to enter cells and inhibits the growth of colon cancer cells. Based on the current research, PEL may be used as a liposomal-assisted colon-specific delivery.

chitosan succinatechitosomes5-fluorouracilcolon-targeted drug delivery
مقالوصول مغلق202411استشهاد· Semantic Scholar

Nicotinamide Loaded Chitosan Nanocomplex Shows Improved Anticancer Potential: Molecular Docking, Synthesis, Characterization and In vitro Evaluations

Current Organic Chemistry · مجلد 28 (1) · 46-55

Abstract: This study aimed to prepare and characterize chitosan nanoparticles encapsulating a nicotinamide derivative (Ni-CS-NP). Additionally, the therapeutic effectiveness, cytotoxicity, selectivity, and immunomodulatory properties of Ni-CS-NP were evaluated in human breast and colon cancer cell lines. Chitosan nanoparticles have shown potential as drug delivery carriers due to their biocompatibility and controlled release properties. Encapsulating a nicotinamide derivative further enhances the therapeutic potential of these nanoparticles. Computational studies were employed to validate the binding interactions, providing crucial insights into the formulation's stability and effectiveness. The primary objective was to assess the cytotoxicity and safety profiles of Ni-CS-NP in human cancer cell lines. Moreover, this study aimed to investigate the specific mechanisms underlying its cytotoxic effects, including its impact on cell cycle progression, apoptosis induction, and immunomodulation. Ni-CS-NP were synthesized using the ionic gelation method and characterized using Fourier-transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and thermo gravimetric analysis. The cytotoxicity was evaluated in breast and colon cancer cell lines through the MTT assay. Selectivity indices were calculated to determine the safety profiles. The inhibition of VEGFR-2, induction of apoptosis, cell cycle disruption, and immunomodulatory effects were assessed through molecular assays. Computational analysis demonstrated favorable binding interactions through the Ni-CS-NP complex. The characterization studies confirmed the successful synthesis of Ni-CS-NP with well-defined structural and thermal properties. Ni-CS-NP exhibited remarkable cytotoxicity with a superior safety profile against MCF7 and HCT 116 cell lines showing IC50 values of 2.32 and 2.70 μM, respectively, surpassing sorafenib's efficacy (IC50 = 4.12 and 7.55 μM, respectively). Additionally, Ni-CS-NP effectively inhibited VEGFR-2, induced both early and late apoptosis, and disrupted the cell cycle progression in MCF7 cells. Notably, Ni-CS-NP demonstrated significant immunomodulatory effects by reducing TNF-α and IL-2 levels compared to dexamethasone. The encapsulation of a nicotinamide derivative within chitosan nanoparticles (Ni-CS-NP) through the ionic gelation method proved successful. Ni-CS-NP displayed potent cytotoxicity, superior safety profiles, and promising immunomodulatory effects in human breast cancer cells. These findings highlight the potential of Ni-CS-NP as a novel therapeutic agent for breast cancer treatment, warranting further investigation for clinical applications.

nicotinamide derivativeschitosan nanoparticlesnanocomplexesanticancer drug delivery